Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Fluid Bolus for Post-induction Hypotension in Elective Cystoscopies
NCT06985654Phase 4Enrolling by invitation
- Sponsor
- University of Missouri
- Start
- Jul 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lactated ringer's solution in hypotension (2 arms), sponsored by University of Missouri. Primary endpoint: Incidence of Postinduction Hypotension up to 24 hours. Started Jul 2025; status: enrolling by invitation.
02
Drugs
lactated ringer's solution
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT06985654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06985654.